GABITRIL 5 mg, film-coated tablet 50 tablets
Active ingredients: Tiagabine hydrochloride monohydrate, Anhydrous tiagabine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GABITRIL 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 50 comprimé(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- TEVA PHARMA (PAYS-BAS)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67859994CIP73412602CIP133400934126024Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TIAGABINE MONOHYDRATÉcomprimé | — | SA |
| TIAGABINE ANHYDREcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.